KRTL BioTech

Analysts slam Shell over buyback delay warning

Analysts slam Shell over buyback delay warning

Analysts on Friday slammed Royal Dutch Shell's warning of possible delays to its $25 billion share buyback as an unnecessary step that undermines the energy giant's management.